HYPERPROLACTINEMIA : INITIATION OF THERAPY IS 0.25 MG TWICE A WEEK. DOSAGE MAY BE INCREASED BY 0.25 MG TWICE WEEKLY UP TO A DOSAGE OF 1 MG TWICE A WEEK ACCORDING TO THE PATIENT'S SERUM PROLACTIN LEVEL.
DOSAGE INCREASES SHOULD NOT OCCUR MORE RAPIDLY THAN EVERY 4 WEEKS.
AFTER A NORMAL SERUM PROLACTIN LEVEL HAS BEEN MAINTAINED FOR 6 MONTHS, CABGOLIN MAY BE DISCONTINUED, WITH PERIODIC MONITORING OF THE SERUM PROLACTIN LEVEL TO DETERMINE WHETHER OR WHEN TREATMENT WITH CABGOLIN SHOULD BE REINSTITUTED.
PREVENTION OF LACTATION, DURING FIRST DAY POSTPARTUM, 1 MG AS A SINGLE DOSE; SUPPRESSION OF ESTABLISHED LACTATION (BUT SEE NOTES ABOVE) 250 MICROGRAMS EVERY 12 HOURS FOR 2 DAYS
PARKINSONISM : INITIALLY 1 MG DAILY, INCREASED BY INCREMENTS OF 0.5 - 1 MG AT 7 OR 14 DAY INTERVALS; USUAL RANGE 2 - 6 MG DAILY
NOTE CONCURRENT DOSE OF LEVODOPA MAY BE DECREASED GRADUALLY WHILE DOSE OF CABERGOLINE IS INCREASED